Imaging in Therapy Response Assessment and Surveillance of Lung Cancer: Evidenced-based Review With Focus on the Utility of 18 F-FDG PET/CT.

Authors :: Sheikhbahaei S
Verde F
Hales RK
Rowe SP
Solnes LB
Source :: Clinical lung cancer [Clin Lung Cancer] 2020 Nov; Vol. 21 (6), pp. 485-497. Date of Electronic Publication: 2020 Jul 03.
Publication Year :: 2020
Abstract: This review covers the state-of-the-art imaging in therapy assessment and surveillance of lung cancer with focus on the utility of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ( <superscript>18</superscript> F-FDG PET/CT). We review different qualitative and quantitative response assessment criteria in lung cancer, common pitfalls and atypical patterns of response to immunotherapy, and imaging features of common immune-related adverse events. In addition, the currently recommended imaging workup in surveillance of asymptomatic patients with non-small-cell and small-cell lung cancer and future developments will be discussed.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)

Subjects :: Animals
Humans
Lung Neoplasms diagnostic imaging
Lung Neoplasms drug therapy
Lung Neoplasms metabolism
Prognosis
Fluorodeoxyglucose F18 metabolism
Immunotherapy methods
Lung Neoplasms pathology
Multimodal Imaging methods
Positron Emission Tomography Computed Tomography methods
Radiopharmaceuticals metabolism

Full Text Access

Tools